The Leibniz Center for Photonics in Infection Research (LPI) is an open-user, one-stop agency.
Its globally unique infrastructure will help revolutionize the development of market-ready light-based diagnostic methods and novel therapeutic approaches for the treatment of infectious diseases. All development steps from concept to medical device are included in a holistic process. This is supported by professional quality management and early consideration of regulatory requirements.
Infectious diseases are among the most common causes of death worldwide. Antibiotic-resistant pathogens complicate treatment. There is an immense need for new therapeutic approaches and rapid diagnostic procedures.
Light-based procedures and artificial intelligence support physicians in their diagnosis and give them a time advantage. Photonics is a powerful tool in the research and development of new therapeutics.
Artificial Intelligence Helps with Data Evaluation and Enables Reliable Diagnostics. Machine learning methods are able to interpret complex measurement data in order to derive diagnostic information.
A Globally Unique Infrastructure for the Development of Market-ready Solutions: LPI bridges the gap from application research to marketable products.
Light-based technologies offer enormous potential in the fight against infectious diseases. Their research as well as the development of effective […]
The build up phase of the Leibniz Center for Photonics in Infection Research (LPI) is now starting with the implementation […]
Light-based methods are increasingly used for analytical problems in the fields of health, environment, medicine and safety. Raman spectroscopy in […]
Excellent science and globally active companies in the fields of optics and photonics, medical technology and analytics as well as a lively start-up scene make scientific and business location Jena an innovation driver in the field of optical health technologies.
The LPI builds on the competencies of the University Hospital and the Friedrich Schiller University as well as the Leibniz Institute of Photonic Technology (Leibniz-IPHT) and Natural Product Research and Infection Biology (Leibniz-HKI) located here. The four supporting institutions participate in the established research associations, DFG special research areas, the „Balance of the MicroVerse“ cluster of excellence as well as federally funded projects such as the „InfectoGnostics“ research campus, the Leibniz science campus „InfectoOptics“ and the „InfectControl2020“ consortium from the „Twenty20 Initiative“ of the Federal Ministry of Education and Research and the „Center for Sepsis and Infection Research“ (Center for Sepsis Control & Care, CSCC).
An initiative of the Leibniz Association in cooperation with
